title: Photodynamic therapy as adjunctive therapy for morpheaform basal cell carcinoma.
abstract: The authors decided to evaluate the possible use of methyl-aminolevulinate photodynamic therapy (MAL-PDT) as adjunctive therapy for morpheaform basal cell carcinoma prior to standard surgical excision in order to reduce tumor size and volume and to facilitate surgical treatment. It was observed that MAL-PDT may be an option as an adjunctive therapy prior to standard surgical excision of morpheaform basal cell carcinoma, leading to less invasive surgery.
authors: Department of Dermatology, Centro Hospitalar do Porto - Hospital de Santo António, Edifício das Consultas Externas do Hospital Geral Santo António, Ex CICAP, 4100 Porto, Portugal. tiagotorres2002@hotmail.com
authors: T
authors: T
authors: Torres
authors: I
authors: I
authors: Fernandes
authors: V
authors: V
authors: Costa
authors: M
authors: M
authors: Selores
mesh_terms: D000622:Aminolevulinic Acid / Q000031:analogs & derivatives; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D022202:Chromosomes, Artificial, Bacterial; D005153:Facial Neoplasms / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D017319:Photosensitizing Agents / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000601:surgery
chemical_list: D017319:Photosensitizing Agents; C475457:methyl 5-aminolevulinate; D000622:Aminolevulinic Acid